$138.05 Original price was: $138.05.$30.00Current price is: $30.00.
This issue of Clinics in Laboratory Medicine, edited by Geza S. Bodor, delves into the diverse and evolving field of Clinical Pathology. The topics covered are extensive, providing insights into the latest trends, techniques, and applications in the field.
Understanding the importance of accurate steroid and salivary cortisol measurements is crucial for diagnosing various endocrine disorders. This section explores the methodologies and clinical implications of these tests.
LCMSMS (Liquid Chromatography-Mass Spectrometry/Mass Spectrometry) has revolutionized protein testing in clinical settings. This topic discusses the advantages and challenges of implementing LCMSMS for protein analysis.
This section focuses on the integration of LCMSMS in routine clinical laboratory practice, highlighting its applications, limitations, and future prospects.
Establishing and maintaining laboratory standards is essential for ensuring the quality and reliability of LCMSMS results. This topic addresses the current standards and guidelines for clinical LCMSMS.
As LCMSMS technology advances, there is an increasing need for laboratory scientists to be trained in its principles, applications, and interpretations. This section emphasizes the importance of education and training in LCMSMS.
MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) mass spectrometry has emerged as a powerful tool in clinical microbiology. This topic explores its applications and potential in identifying microorganisms.
This section delves deeper into the use of MALDI TOF MS in clinical microbiology, discussing its role in rapid bacterial identification and antimicrobial resistance testing.
Developing and validating LCMSMS methods for clinical use requires careful consideration of several factors. This topic outlines the key considerations and challenges involved.
Mass spectrometry has shown great promise in cancer diagnosis, particularly in the detection of biomarkers. This section discusses the current state and future prospects of mass spectrometry in cancer diagnostics.
LCMSMS plays a critical role in detecting drug adulteration and ensuring the quality of pharmaceutical products. This topic covers the applications and challenges of LCMSMS in drug testing.
LCMSMS has significantly improved the diagnosis and monitoring of inherited metabolic disorders. This section highlights the clinical utility of LCMSMS in this context.
Harmonizing LCMSMS protein assays is essential for ensuring the comparability of results across different laboratories. This topic discusses the efforts and challenges involved in achieving harmonization.
This section compares and contrasts the use of LCMSMS and immunoassay for vitamin D testing, discussing the advantages and limitations of each method.
LCMSMS has become an indispensable tool in pain management testing, particularly in the detection of opioids and other drugs. This topic explores the applications and challenges of LCMSMS in this context.
The development of FDA-approved clinical mass spectrometers is crucial for ensuring the safety and efficacy of these instruments in clinical settings. This section discusses the regulatory pathways and challenges involved.
Author |
---|
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline